In addition, considering the relevance of race/ethnicity to the outcome of the disease, we studied the utility of two biomarkers, PTEN and ERG, in a population of PCa patients from Northeastern Brazil, a diverse geographical region with no previous study. The gene discussed is PTEN; the disease is posterior cortical atrophy.